Health
Second-generation double antibody protects from SARS-CoV-2 and its tested variants – News-Medical.Net
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation…
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation ‘double antibody’ that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.
Antibody-based immunotherapy was already shown to be effective against COVID-19 but faces two main obstacles: it needs to work against the circulating viral variants;…
-
Business22 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News19 hours agoWilliam Robinson dies aged 89
-
General18 hours agoMatt Wright wanted to hinder investigations into chopper crash ‘at almost any cost’, jury hears
-
Business20 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025